4//SEC Filing
Watson David O. 4
Accession 0001492422-26-000017
CIK 0001492422other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 6:48 PM ET
Size
8.8 KB
Accession
0001492422-26-000017
Insider Transaction Report
Form 4
Watson David O.
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2026-01-07$14.95/sh+888$13,276→ 104,618 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-07−888→ 14,000 totalExercise: $14.95Exp: 2028-02-15→ Common Stock (888 underlying)
Holdings
- 10,000(indirect: By Children)
Common Stock
- 50,136(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This represents a custodial account held by the reporting person for the sole benefit of his minor children.
- [F2]The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
- [F3]This option was granted on February 16, 2018 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001657719
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 6:48 PM ET
- Size
- 8.8 KB